CEN BIOTECH INC Quarterly Operating Income (Loss) in USD from Q1 2015 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cen Biotech Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2015 to Q3 2022.
  • Cen Biotech Inc Operating Income (Loss) for the quarter ending September 30, 2022 was -$486K, a 24.6% increase year-over-year.
  • Cen Biotech Inc Operating Income (Loss) for the twelve months ending September 30, 2022 was -$2.71M, a 84.6% increase year-over-year.
  • Cen Biotech Inc annual Operating Income (Loss) for 2021 was -$19M, a 648% decline from 2020.
  • Cen Biotech Inc annual Operating Income (Loss) for 2020 was -$2.54M, a 1.4% increase from 2019.
  • Cen Biotech Inc annual Operating Income (Loss) for 2019 was -$2.58M, a 41% increase from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$2.71M -$486K +$159K +24.6% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$2.87M -$300K +$16M +98.2% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-22
Q1 2022 -$18.8M -$140K +$205K +59.4% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-20
Q4 2021 -$19M -$1.78M -$1.43M -404% Oct 1, 2021 Dec 31, 2021 10-K 2022-04-14
Q3 2021 -$17.6M -$645K +$323K +33.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$17.9M -$16.3M -$15.6M -2256% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
Q1 2021 -$2.36M -$345K +$186K +35% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-20
Q4 2020 -$2.54M -$354K +$307K +46.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-14
Q3 2020 -$2.85M -$968K -$451K -87.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-19
Q2 2020 -$2.4M -$690K +$306K +30.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$2.71M -$531K -$126K -31% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$2.58M -$661K +$1.45M +68.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 -$4.03M -$517K +$123K +19.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$4.15M -$997K -$27.9K -2.88% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 -$4.12M -$405K +$247K +37.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-12
Q4 2018 -$4.37M -$2.11M +$7.88M +78.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-14
Q3 2018 -$12.3M -$640K -$89.4K -16.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-18
Q2 2018 -$12.2M -$969K -$363K -60% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-19
Q1 2018 -$11.8M -$652K -$188K -40.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 -$11.6M -$9.99M -$4.02M -67.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 -$7.59M -$551K -$368K -201% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$7.23M -$605K -$368K -154% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$6.86M -$465K -$268K -136% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$6.59M -$5.97M -$5.53M -1241% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-16
Q3 2016 -$1.06M -$183K +$17.8K +8.87% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 -$1.08M -$238K -$151K -173% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 -$930K -$197K +$115K +36.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-22
Q4 2015 -$1.04M -$445K Oct 1, 2015 Dec 31, 2015 10-K 2017-04-13
Q3 2015 -$200K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$87.2K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$312K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.